HAP Trading’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
HAP Trading's NVAX Position: Q2 2022 in Review
HAP Trading sold out of Novavax (NVAX) in Q2 2022, closing a stake of 64,638 shares — an estimated $3.35M sold.
HAP Trading first reported a position in NVAX in Q2 2020 and held it in 5 quarters. The position peaked at $4.76M in Q1 2022. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- HAP Trading reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- HAP Trading sold 64,638 Novavax shares in Q2 2022, an estimated $3.35M.
- HAP Trading first reported a position in Novavax in Q2 2020 and held it in 5 quarters.
- HAP Trading's Novavax position peaked at $4.76M in Q1 2022.
- 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.